The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib
Abstract Cytokeratin 19-positive (CK19+) hepatocellular carcinoma (HCC) is an aggressive subtype characterized by early recurrence and chemotherapy tolerance. However, there is no specific therapeutic option for CK19+ HCC. The correlation between tumor recurrence and expression status of CK19 were s...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Publishing Group
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/0c2f2212cdcf45f8b489bd9024689604 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|